NeuroBo Pharmaceuticals I... (NRBO)
NASDAQ: NRBO
· Real-Time Price · USD
2.36
null (null%)
At close: Nov 27, 2024, 9:00 PM
undefined% (1D)
| Bid | 2.31 |
| Market Cap | 20.33M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -27.73M |
| EPS (ttm) | -4.29 |
| PE Ratio (ttm) | -0.5501165501165501 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.68 |
| Volume | 0 |
| Avg. Volume (20D) | 0 |
| Open | undefined |
| Previous Close | undefined |
| Day's Range | 2.36 - 2.36 |
| 52-Week Range | 2.36 - 2.36 |
| Beta | -0.28 |
About NRBO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRBO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRBO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
NeuroBo Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
10 months ago
NeuroBo Pharmaceuticals shares are trading higher after a Form4 filing disclosed that Dong-A ST bought 2.54 million shares at an average price of $3.13 per share.
